The goal of this research is to design and develop a computational systems biology-based platform for rational and effective screening of drug combinations in silico. The platform complements traditional drug discovery by facilitating early discovery of combination therapy and guiding design of further wet lab experiments both in vitro and in vivo.
Related publications (selected):
Related websites: INGOT